ForSight Robotics, the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world’s first surgical platform for fully robotic cataract surgery: ORYOM. ForSight’s flagship robotic platform will increase accessibility to ophthalmic surgery procedures .
The Israeli startup is developing ORYOM, a hybrid intraocular robotic ophthalmic platform, to advance ophthalmic surgery to treat a wide range of conditions including cataract, glaucoma, and other retinal diseases
Israeli Robotics Startup Raises $55 Million for First-Ever Fully Robotic Cataract Surgery | The Jewish Press - JewishPress.com | Hana Levi Julian | 20 Tammuz 5782 – July 18, 2022 jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) has cleared the QUATERA® 700 , a revolution in phaco.